Skip to content
stoqly

ACM Research, Inc.

ACMR Nasdaq Special Industry Machinery, Nec Financials FY2016–FY2025

Revenue Total sales reported in the income statement.
$901M
15.2% vs prior year
Operating margin Operating income as a share of revenue.
12.1%
7.2 pts
Net income Profit after all expenses, interest and tax.
$94.1M
9.2%
Free cash flow Cash from operations minus capital spending.
βˆ’$66.6M
195.2%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
10.3%
7.8 pts
Market cap Last close times the latest diluted share count, so it is approximate.
β€”
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”
On $2.10 EPS (TTM)

What ACM Research, Inc. does

No business description yet.

Legal name
ACM Research, Inc.
Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Mar 2, 2026
Accession Β· CIK
0001628280-26-013231
0001680062

Revenue and margins

ACM Research, Inc. had $901M of revenue in fiscal 2025, up 15.2% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 25.3% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was βˆ’$66.6M in fiscal 2025, βˆ’7.4% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

ACM Research, Inc. returned β€” to shareholders in fiscal 2025. The diluted share count rose 1.6%.

Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably ACM Research, Inc. can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $592M$268M$203M$427M$793M
Debt incl. finance leases $35.0M$77.0M$92.1M$183M$288M
Net debt / EBITDA βˆ’13.6xβˆ’3.0xβˆ’1.1xβˆ’1.5xβˆ’4.1x
Debt / equity 0.1x0.1x0.1x0.2x0.2x
Interest coverage 50.6x35.7x35.7x36.4x15.7x
Current ratio 4.6x2.4x2.3x2.3x3.3x
Quick ratio 3.6x1.4x1.3x1.4x2.3x
Total assets $1.1B$1.2B$1.5B$1.9B$2.9B
Total liabilities $241M$423M$565M$760M$942M
Shareholders' equity $676M$675M$767M$905M$1.5B
Net debt (βˆ’ = net cash) βˆ’$557Mβˆ’$191Mβˆ’$111Mβˆ’$244Mβˆ’$505M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Net income is positive βœ“ βœ• βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Cash from operations is positive βœ• βœ• βœ“ βœ“ βœ• βœ• βœ• βœ• βœ“ βœ•
Return on assets rose β€” βœ• βœ“ βœ“ βœ• βœ• βœ• βœ“ βœ“ βœ•
Cash from operations exceeds net income βœ• βœ• βœ“ βœ• βœ• βœ• βœ• βœ• βœ“ βœ•
Debt fell relative to assets β€” βœ“ βœ• βœ“ βœ• βœ“ βœ• βœ“ βœ• βœ•
Current ratio rose β€” βœ“ βœ• βœ“ βœ• βœ“ βœ• βœ• βœ• βœ“
Share count didn't rise β€” βœ• βœ• βœ• βœ• βœ• βœ“ βœ“ βœ• βœ•
Gross margin rose β€” βœ• βœ• βœ“ βœ• βœ• βœ“ βœ“ βœ“ βœ•
Revenue rose relative to assets β€” βœ• βœ“ βœ• βœ• βœ• βœ“ βœ“ βœ“ βœ•
F-score β€” / 32 / 95 / 96 / 91 / 93 / 94 / 96 / 96 / 92 / 9
Accruals ratio 10.6%13.9%βˆ’0.4%5.9%11.6%11.2%8.9%11.2%βˆ’2.9%4.4%
Altman Z'' 3.155.054.576.844.908.055.265.175.236.15

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $27.4M $36.5M $74.6M $108M $157M $260M $389M $558M $782M $901M
Net interest income βˆ’$0.3M βˆ’$0.8M $1.3M β€” β€” β€” β€” β€” β€” β€”
Gross profit $13.3M $17.2M $34.4M $50.7M $69.6M $115M $184M $276M $392M $400M
Research and development $3.3M $5.1M $10.4M $12.9M $19.1M $34.2M $62.2M $92.7M $105M $145M
Operating income $3.5M $0.7M $6.5M $17.8M $21.5M $38.7M $59.0M $95.8M $151M $109M
Interest expense $0.2M $0.3M $0.5M $0.7M $1.0M $0.8M $1.7M $2.7M $4.2M $7.0M
Pretax income $3.0M βˆ’$0.3M $7.4M $18.9M $19.3M $43.1M $67.4M $116M $166M $135M
Income tax $0.6M $0.5M $0.8M βˆ’$0.5M βˆ’$2.4M $0.1M $16.8M $19.4M $35.0M $13.3M
Net income $1.0M βˆ’$0.3M $6.6M $18.9M $18.8M $37.8M $39.3M $77.3M $104M $94.1M
Net income to common $0.6M βˆ’$0.3M $6.6M $18.9M $18.8M $37.8M $39.3M $77.3M $104M $94.1M
Diluted EPS $0.18 βˆ’$0.05 $0.37 $0.99 $0.30 $0.58 $0.59 $1.16 $1.53 $1.37
Diluted shares 0.00B 0.01B 0.02B 0.02B 0.06B 0.07B 0.07B 0.06B 0.07B 0.07B
Cash flow
Cash from operations βˆ’$3.7M βˆ’$8.1M $6.9M $9.4M βˆ’$13.5M βˆ’$40.1M βˆ’$62.2M βˆ’$75.3M $152M βˆ’$10.3M
Capital expenditure $0.8M $0.7M $1.8M $1.0M $5.2M $9.2M $91.1M $61.9M $82.5M $56.3M
Free cash flow βˆ’$4.5M βˆ’$8.8M $5.1M $8.4M βˆ’$18.8M βˆ’$49.2M βˆ’$153M βˆ’$137M $70.0M βˆ’$66.6M
Depreciation and amortization $0.2M $0.3M $0.4M $0.8M $1.1M $2.4M $4.8M $6.9M $6.6M $14.4M
Stock-based compensation $0.4M $1.6M $3.4M $3.6M $5.6M $5.1M $7.7M $27.3M $49.6M $33.6M
Share buybacks β€” β€” $0.0M $2.8M $0.0M $0.0M β€” β€” β€” β€”
Dividends and buybacks β€” β€” $0.0M $2.8M $0.0M $0.0M β€” β€” β€” β€”
Balance sheet
Cash and short-term investments $10.1M $17.7M $27.1M $58.3M $100M $592M $268M $203M $427M $793M
Total debt $4.8M $5.1M $9.4M $13.8M $45.7M $35.0M $77.0M $92.1M $183M $288M
Current assets $40.3M $62.9M $96.0M $198M $261M $953M $964M $1.2B $1.5B $2.4B
Current liabilities $17.1M $21.8M $46.1M $53.5M $103M $206M $396M $501M $641M $746M
Inventory $11.7M $15.4M $38.8M $44.8M $88.6M $218M $393M $545M $598M $703M
Property and equipment, net $2.3M $2.3M $3.7M $3.6M $8.2M $14.0M $82.9M $202M $269M $315M
Intangible assets $0.0M $0.1M $0.3M $0.3M $0.6M $0.5M $1.3M $2.5M $3.5M $2.8M
Total assets $44.5M $67.9M $103M $218M $341M $1.1B $1.2B $1.5B $1.9B $2.9B
Total liabilities $23.9M $28.0M $50.7M $60.2M $133M $241M $423M $565M $760M $942M
Shareholders' equity βˆ’$2.4M $39.9M $52.3M $97.3M $141M $676M $675M $767M $905M $1.5B
Margins
Gross margin 48.7% 47.2% 46.2% 47.1% 44.4% 44.2% 47.2% 49.5% 50.1% 44.4%
Operating margin 12.8% 1.9% 8.7% 16.5% 13.7% 14.9% 15.2% 17.2% 19.3% 12.1%
EBITDA margin 13.4% 2.7% 9.2% 17.3% 14.4% 15.8% 16.4% 18.4% 20.1% 13.7%
Net margin 3.8% βˆ’0.9% 8.8% 17.6% 12.0% 14.5% 10.1% 13.9% 13.2% 10.4%
FCF margin βˆ’16.4% βˆ’24.0% 6.8% 7.8% βˆ’12.0% βˆ’19.0% βˆ’39.4% βˆ’24.6% 8.9% βˆ’7.4%
Net interest share of revenue βˆ’1.3% βˆ’2.2% 1.7% β€” β€” β€” β€” β€” β€” β€”
Returns
Return on capital β€” 2.0% 16.6% 33.7% 24.7% 32.4% 9.2% 12.2% 18.0% 10.3%
Return on capital employed 12.7% 1.5% 11.4% 10.8% 9.0% 4.6% 7.0% 9.7% 12.4% 5.1%
Return on equity β€” βˆ’1.7% 14.3% 25.3% 15.8% 9.2% 5.8% 10.7% 12.4% 7.9%
Return on assets 2.3% βˆ’0.6% 7.7% 11.8% 6.7% 5.4% 3.4% 5.7% 6.2% 4.0%
Return on tangible equity β€” βˆ’0.8% 12.6% 19.5% 13.4% 5.6% 5.8% 10.1% 11.5% 6.4%
Growth
Revenue growth β€” 33.4% 104.5% 44.1% 45.7% 65.8% 49.7% 43.4% 40.2% 15.2%
Net income growth β€” βˆ’130.8% β€” 187.4% βˆ’0.6% 101.0% 4.0% 97.0% 34.0% βˆ’9.2%
EPS growth β€” βˆ’127.8% β€” 167.6% βˆ’69.7% 93.3% 1.7% 96.6% 31.9% βˆ’10.5%
FCF growth β€” β€” β€” 66.0% βˆ’322.5% β€” β€” β€” β€” βˆ’195.2%
Share count change β€” 81.0% 160.9% 6.8% 232.1% 2.8% βˆ’0.0% βˆ’0.7% 2.1% 1.6%
Financial health
Net debt / EBITDA βˆ’1.5x βˆ’13.0x βˆ’2.6x βˆ’2.4x βˆ’2.4x βˆ’13.6x βˆ’3.0x βˆ’1.1x βˆ’1.5x βˆ’4.1x
Debt / equity β€” 0.1x 0.2x 0.1x 0.3x 0.1x 0.1x 0.1x 0.2x 0.2x
Interest coverage 19.3x 2.5x 13.0x 23.9x 21.9x 50.6x 35.7x 35.7x 36.4x 15.7x
Current ratio 2.4x 2.9x 2.1x 3.7x 2.5x 4.6x 2.4x 2.3x 2.3x 3.3x
Quick ratio 1.7x 2.2x 1.2x 2.9x 1.7x 3.6x 1.4x 1.3x 1.4x 2.3x
Capital allocation
Capex / revenue 2.9% 1.8% 2.5% 0.9% 3.3% 3.5% 23.4% 11.1% 10.5% 6.2%
Stock comp / revenue 1.4% 4.4% 4.5% 3.3% 3.6% 2.0% 2.0% 4.9% 6.3% 3.7%
Payouts / FCF β€” β€” 0.0% 33.5% β€” β€” β€” β€” β€” β€”
Quality scores
Piotroski F-score β€” 2.0 5.0 6.0 1.0 3.0 4.0 6.0 6.0 2.0
Altman Z'' 3.1 5.1 4.6 6.8 4.9 8.1 5.3 5.2 5.2 6.1
Accruals ratio 10.6% 13.9% βˆ’0.4% 5.9% 11.6% 11.2% 8.9% 11.2% βˆ’2.9% 4.4%

Source: SEC EDGAR XBRL filings (CIK 0001680062). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open